ResearcherJapan Agency for Medical Research and DevelopmentNo recent work listed
Erina Takai
Matched on OpenAlex author ID A5010965484. Sources: OpenAlex.
Their work
- Papers
- 10
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2015: 2 papers · 2016: 4 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 10
- Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic cancer patients. Co-author DOI 10.1038/s41598-023-30131-y↗
- Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000004213↗
- Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1038/s41598-019-53271-6↗
- Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines. Co-author DOI 10.1007/s00535-018-1466-y↗
- Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer. Co-author DOI 10.1007/978-3-319-42044-8_3↗
- Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000574↗
- Germline mutations in Japanese familial pancreatic cancer patients. Co-author DOI 10.18632/oncotarget.12490↗
- Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. Co-author DOI 10.3748/wjg.v22.i38.8480↗
- Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer. Co-author DOI 10.1038/srep18425↗
- Genomic alterations in pancreatic cancer and their relevance to therapy. Co-author DOI 10.4251/wjgo.v7.i10.250↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shinichi Yachida · 10 shared papers, 2015–2023 · strength 0.90
- Paper Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic… DOI 10.1038/s41598-023-30131-y↗
- Paper Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer. DOI 10.1097/sla.0000000000004213↗
- Paper Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. DOI 10.3748/wjg.v22.i38.8480↗
- Chigusa Morizane · 6 shared papers, 2015–2023 · strength 0.52
- Paper Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic… DOI 10.1038/s41598-023-30131-y↗
- Paper Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer. DOI 10.1097/sla.0000000000004213↗
- Paper Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Beth… DOI 10.1007/s00535-018-1466-y↗
- Akihiro Ohmoto · 4 shared papers, 2016–2022 · strength 0.32
- Paper Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer. DOI 10.1097/sla.0000000000004213↗
- Paper Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Beth… DOI 10.1007/s00535-018-1466-y↗
- Paper Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Aden… DOI 10.1097/mpa.0000000000000574↗
- Takuji Okusaka · 4 shared papers, 2015–2018 · strength 0.23
- Paper Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Beth… DOI 10.1007/s00535-018-1466-y↗
- Paper Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Aden… DOI 10.1097/mpa.0000000000000574↗
- Paper Germline mutations in Japanese familial pancreatic cancer patients. DOI 10.18632/oncotarget.12490↗
- Junji Furuse · 2 shared papers, 2016–2022 · strength 0.19
- Toru Furukawa · 2 shared papers, 2016–2022 · strength 0.19
- Kazuaki Shimada · 3 shared papers, 2015–2018 · strength 0.18
- Paper Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Beth… DOI 10.1007/s00535-018-1466-y↗
- Paper Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Aden… DOI 10.1097/mpa.0000000000000574↗
- Paper Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer. DOI 10.1038/srep18425↗
- Susumu Hijioka · 1 shared paper, 2023 · strength 0.16
- Akihiro Ohba · 1 shared paper, 2023 · strength 0.16
- Junko Tanaka · 1 shared paper, 2023 · strength 0.16
- Chihiro Uematsu · 1 shared paper, 2023 · strength 0.16
- Takahide Yokoi · 1 shared paper, 2023 · strength 0.16
- Masakazu Yamamoto · 1 shared paper, 2022 · strength 0.13
- Hideki Ueno · 2 shared papers, 2015–2018 · strength 0.12
- Jee-Soo Lee · 1 shared paper, 2019 · strength 0.08
- Pierre Laurent‐Puig · 1 shared paper, 2019 · strength 0.08
- Daniel Pietrasz · 1 shared paper, 2019 · strength 0.08
- Dae Young Zang · 1 shared paper, 2019 · strength 0.08
- Young Kyung Lee · 1 shared paper, 2019 · strength 0.08
- Jean‐Baptiste Bachet · 1 shared paper, 2019 · strength 0.08
- Sun‐Young Kong · 1 shared paper, 2019 · strength 0.08
- Ralph H. Hruban · 1 shared paper, 2016 · strength 0.05
- Hitoshi Nakagama · 1 shared paper, 2015 · strength 0.04
- Satoshi Nara · 1 shared paper, 2015 · strength 0.04
- Hideyuki Hayashi · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.